ATX 4.69% 6.1¢ amplia therapeutics limited

Yes, but management may also consider exclusive licensing deal...

  1. 4,061 Posts.
    lightbulb Created with Sketch. 140
    Yes, but management may also consider exclusive licensing deal with performance milestones to somewhat de-risk the binary event.

    Maybe ATX are considering a licensing deal with a Major Korean pharma as we speak.

    JMHO, DYOR.
 
watchlist Created with Sketch. Add ATX (ASX) to my watchlist
(20min delay)
Last
6.1¢
Change
-0.003(4.69%)
Mkt cap ! $16.56M
Open High Low Value Volume
6.4¢ 6.4¢ 6.1¢ $14.71K 240.6K

Buyers (Bids)

No. Vol. Price($)
1 6872 6.1¢
 

Sellers (Offers)

Price($) Vol. No.
6.4¢ 11099 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
ATX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.